fullerene c60 has been researched along with Diabetes Mellitus, Adult-Onset in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Li, X; Liang, B; Liu, X; Ran, L; Shao, S; Wang, C; Wang, X; Wu, J; Wu, Y; Zeng, L; Zhao, J; Zhen, M | 1 |
| Bai, C; Lei, J; Lin, D; Mo, Y; Sun, Y; Wei, G; Xie, L; Yang, X | 1 |
| Bai, C; Deng, R; Li, X; Shu, C; Wang, C; Wu, Y; Yu, T; Zhen, M; Zhou, C | 1 |
3 other study(ies) available for fullerene c60 and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Functionalized gadofullerene ameliorates impaired glycolipid metabolism in type 2 diabetic mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Fullerenes; Glycolipids; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL | 2022 |
Influence of fullerenol on hIAPP aggregation: amyloid inhibition and mechanistic aspects.
Topics: Amyloid; Diabetes Mellitus, Type 2; Fullerenes; Humans; Islet Amyloid Polypeptide; Molecular Dynamics Simulation; Protein Aggregation, Pathological | 2019 |
Gadofullerene Nanoparticles Reverse Dysfunctions of Pancreas and Improve Hepatic Insulin Resistance for Type 2 Diabetes Mellitus Treatment.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fullerenes; Glucose; Humans; Insulin Resistance; Liver; Mice; Mice, Inbred NOD; Pancreas | 2019 |